Activities & Operations

Best practices for DCT approaches

Best practices for DCT approaches

Many of the best practices for DCTs are the same as in more conventional trial designs. However, some areas of DCT design and planning need additional attention to make the trial successful and to improve the participant experience.

What approaches can we use to move trial activities towards participants’ homes?

What approaches can we use to move trial activities towards participants’ homes?

Several approaches have been used in DCTs to move trial activities towards participants’ homes. A selection of these, which were used in RADIAL, are shown in the figure below. Others include postal or telephone contact…

Remote recruitment and (pre-)screening

Remote recruitment and (pre-)screening

DCTs minimise or eliminate the need for travel to research sites, enabling broader accessibility for participants who are not in convenient proximity to a trial site. This enables broader outreach to potential participants through online recruitment…

Remote consent

Remote consent

Remote consent is a key decentralised element in DCTs that enables participants to give their consent to participate in a trial without a visit to the trial centre. In a DCT, the process usually take place online (eConsent) through identification online…

Participant diversity and representativeness

Participant diversity and representativeness

DCTs have significant potential to reduce logistical barriers and improve accessibility. This can enable the participation of traditionally underserved populations, ensuring that findings are applicable to more segments of the population…

Retention

Retention

Retention in a clinical trial refers to the number or proportion of participants who complete the study through to the end. The ease of participation in a DCT may improve retention as continued participation may be more flexibly managed around…

Carbon footprint

Carbon footprint

It has been reported that the pharmaceutical industry is among the highest producers of greenhouse gas emissions. Carbon footprinting can be used to identify which elements of DCTs have the greatest impact on greenhouse gas emissions…

Home shipment and collection

Home shipment and collection

NEED COP FOR THIS BOX…

Home Nursing in DCTs

Home Nursing in DCTs

Home nursing is a specialty in which nurses or other healthcare professionals (HCPs) provide multidimensional care to patients outside of the traditional site. Including home nursing as a DCT element can make it more convenient for the participant…

Economic insights when introducing decentralized trial elements

Economic insights when introducing decentralized trial elements

Setting up and conducting clinical trials is costly, and concerns have been raised that expenditures are expected to increase. DCTs have the potential to achieve cost-savings, if they can accelerate patient recruitment and improve retention…

Data quality

Data quality

NEED COP FOR THIS BOX…

Patient Considerations & Involvement

What motivates people to participate in a clinical trial (from home)

What motivates people to participate in a clinical trial (from home)

DCTs are expected to be less burdensome for participants than conventional trials, as travel to the site is reduced or eliminated and trial visits can be carried out from the participant’s home or immediate vicinity by applying digital technologies.

Participant Experience with DCT approaches

Participant Experience with DCT approaches

When introducing something as novel as decentralised trial elements to participants, the impact on participant experiences is an important component to evaluate.

Patient involvement and engagement in research consortiums

Patient involvement and engagement in research consortiums

It is important to involve people with lived experience at all stages of research because only they know what it’s like to live with a particular condition.

Assessment & Approval

The EU Regulatory landscape regarding DCT

The EU Regulatory landscape regarding DCT

Prior to the implementation of the Clinical Trials Regulation (EU No. 536/2014), clinical trials in the EU were governed by EU directives (2001/20/EC, 2005/28/EC) and national laws, with variability across Member States (MS). In 2022, the Clinical Trials Regulation (CTR) became mandatory in all MS…

Overarching ethical considerations for DCTs

Overarching ethical considerations for DCTs

All clinical trials require ethical review, including DCTs.  However, the regulatory and ethical review system was designed for conventional (site-based) trials. To fully realise the promises of DCT approaches, the ethical context needs to be aligned with the practice of DCTs to safeguard responsible conduct.

Health Technology Assessment awareness regarding DCTs

Health Technology Assessment awareness regarding DCTs

Health technology assessment (HTA) bodies are responsible for evaluating new health technologies to support reimbursement decision-making in Europe. As data from DCTs may be used for clinical or economic evaluation (for reimbursement purpose)…

Oversight & Clinical Management

DCT readiness and training of clinical study staff

DCT readiness and training of clinical study staff

In conventional trials, sites traditionally serve as central locations for patient recruitment, monitoring and data collection, and regulatory compliance. In a DCT these traditional roles change, shifting some trial activities away from sites to remote settings.

Privacy & data protection

Privacy & data protection

The successful and sustainable adoption of DCTs hinges on robust data privacy and protection measures. Moving trial activities outside traditional research sites significantly increases the complexity of data flows and amplifies privacy and data protection challenges, such as participant personal data being shared to third party service providers.

PI responsibilities, oversight and safety reporting

PI responsibilities, oversight and safety reporting

PI responsibilities are the same in DCT approaches as they are in any trial. And requirements for oversight and safety reporting need to be neither higher nor lower than in conventional clinical trials. However, different tools may be used to guarantee oversight when participants come to site less or not at all.

Technology & Support

Technology Components

Technology Components

Digital tools in DCTs can improve real-world data collection, reduce participant travel, and offer more flexible engagement. However, there are challenges that come from integrating technology into trials: (1) reliance on cutting-edge yet immature technologies, (2) increased trial complexity, and (3) potential overload for clinical sites and participants.

DCT technical support system for sites and trial participants

DCT technical support system for sites and trial participants

Decentralized clinical trials (DCTs) involve a range of digital tools provided to ….. Often these tools are provided by different, specialised vendors, which can complicate support and coordination. To address this, the RADIAL trial implemented a centralized technical support system for study teams, site staff, and clinical research associates (CRAs).